07 J uly 2014

SOLICITORGENERALHERMESL.OCAMPO
Office of the Solicitor General
134 Amorsolo St., Legaspi Village, Makati City




RE: LETTER REQUESTS DATED 17 JUNE 2014 ON ABORTIFACIENT METHODS
----------------------------------------------------------------------------------------

Dear Hon. Secretary and Director General:

This is regarding our separate letters dated 17 J une 2014 requesting for
your guidance on these specific queries:
1. Are there MODERN NATURAL FAMILY PLANNING METHODS that have
any primary, secondary or tertiary effect as an abortifacient?

2. Are there specific kinds and brands of PILLS that do not have any
primary, secondary or tertiary effect as an abortifacient?

3. Are there specific kinds and brands of INTRA-UTERINE-DEVICES
(IUD) that do not have any primary, secondary or tertiary effect as
an abortifacient?

to which your legal counsel1 replied to as follows:
We refer to your letter dated June 17, 2014
addressed to our client the Food and Drugs Administration
(FDA) requesting for guidance on several matters.

Please be informed that the FDA and the Department of
Health are well aware of their duties and responsibilities
under the Constitution and the Imbong decision and both




----------------------------------------------------------------
1 See Letter dated 02 J uly 2014 from Assistant Solicitor General Hermes L. Ocampo, sent
through electronic mail from the Office of the Solicitor Generals communications Secretariat
at secretariat.osg@gmail.com.

DR. KENNETH Y. HARTIGAN GO

Director General
Philippine Food and Drug Adminstration
Civic Drive, Filinvest Corporate City
Alabang, Muntinlupa City

HON. ENRIQUE T. ONA
Secretary
Philippine Department of Health (DOH)
San Lazaro Compound, City of Manila; and:

HON. JANETTE L. GARIN
Undersecretary
Women, Children and Family Health Cluster

4
DR. ELMER G. PUNZALAN
Assistant Secretary
Office for Special Concerns
Department of Health


DR. IVANHOE C. ESCARTIN
OIC, Director IV
National Center for Health Promotion
Department of Health